BioLineRx Ltd.
BLRX
$2.94
-$0.16-5.16%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.17M | 40.06M | 28.17M | 42.99M | 25.97M |
| Total Receivables | 3.96M | 3.84M | 3.34M | 1.19M | 315.00K |
| Inventory | 3.54M | 3.63M | 2.89M | 1.95M | 1.35M |
| Prepaid Expenses | 1.17M | 1.58M | 1.29M | 1.05M | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.85M | 49.11M | 35.69M | 47.18M | 28.81M |
|
|
|||||
| Total Current Assets | 37.85M | 49.11M | 35.69M | 47.18M | 28.81M |
| Net Property, Plant & Equipment | 1.65M | 1.80M | 1.72M | 1.89M | 2.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.25M | 13.69M | 14.19M | 14.85M | 22.03M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 52.74M | 64.60M | 51.60M | 63.93M | 52.86M |
|
|
|||||
| Total Accounts Payable | 4.63M | 6.27M | 8.26M | 10.87M | 8.44M |
| Total Accrued Expenses | -- | -- | -- | 3.27M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.34M | 11.16M | 4.15M | 3.67M | 3.60M |
| Total Finance Division Other Current Liabilities | 9.99M | 13.09M | 11.48M | 13.05M | 2.68M |
| Total Other Current Liabilities | 9.99M | 13.09M | 11.48M | 13.05M | 2.68M |
| Total Current Liabilities | 24.96M | 30.52M | 23.89M | 30.85M | 14.73M |
|
|
|||||
| Total Current Liabilities | 24.96M | 30.52M | 23.89M | 30.85M | 14.73M |
| Long-Term Debt | 17.98M | 18.79M | 5.94M | 6.63M | 8.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.29M | 1.31M | 1.23M | 1.29M | 1.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 7.49M | 11.93M | 15.29M |
| Total Liabilities | 44.24M | 50.62M | 38.54M | 50.70M | 39.72M |
|
|
|||||
| Common Stock & APIC | 387.44M | 386.84M | 386.84M | 386.84M | 373.79M |
| Retained Earnings | -396.64M | -390.82M | -391.30M | -390.61M | -376.72M |
| Treasury Stock & Other | 17.71M | 17.96M | 17.53M | 16.99M | 16.06M |
| Total Common Equity | 8.51M | 13.98M | 13.06M | 13.22M | 13.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.51M | 13.98M | 13.06M | 13.22M | 13.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.51M | 13.98M | 13.06M | 13.22M | 13.13M |
|
|
|||||
